HIMS vs NBIX
Hims & Hers Health vs Neurocrine Biosciences — AI-powered side-by-side comparison
| Metric | HIMS | NBIX |
|---|---|---|
| AI Score | 49 | 66 |
| Price | $27.77 | $166.76 |
| P/E Ratio | -555.40× | 23.66× |
| ROE | 0.2% | 0.1% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 1.0% |
| Debt / Equity | 2.54× | 0.10× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 39.2 | 36.6 |
| Beta | 2.342 | 0.3859 |
| Expected Upside | +14.7% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HIMS Full Analysis
NBIX Full Analysis